2021 IPO

PROCEPT BioRobotics Stock

Medical device company

Sign up today and learn more about PROCEPT BioRobotics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2009

Notable Investors

Novo Holdings

Headquarters

Redwood Shores CA, US

Total Funding

$201M

About PROCEPT BioRobotics Stock

PROCEPT BioRobotics is a clinical-stage medical device company based in Silicon Valley. The Company has developed a disruptive surgical product for transurethral resection of prostate tissue – The AquaBeam® – and other treatment and diagnostic applications. The AquaBeam is a personalized image-guided tissue removal system, which utilizes proprietary heat-free high-velocity waterjet technology to resect and remove a predetermined volume of tissue with precise and automated incisions conforming to the shape of the prostate.

Investors

Funding History

October 2013$6.0M
August 2014$2.0M
July 2015$7.7M
July 2015$42.0M
June 2017$25.0M
February 2018$118M

Management

Co-Founder & Chief Executive Officer

Nikolai Aljuri

Chief Financial Officer

Kevin Waters

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo